Target intelligence / Profile preview

Small conductance calcium-activated potassium channel protein 2 (SK2)

Target
SK2
Molecular classification
Potassium Channel, Ion Channel, KCNN Family
01

Overview

KCNN2 encodes the small conductance calcium-activated potassium channel protein 2, also known as SK2 or KCa2.2. This is an integral membrane protein that forms a voltage-independent, calcium-activated potassium channel. The channel is composed of four subunits and includes calmodulin-binding domains; calmodulin remains constitutively attached to the C terminus and confers Ca²⁺ sensitivity to the channel. KCNN2 channels mediate voltage-independent transmembrane transfer of potassium ions activated solely by intracellular Ca²⁺ levels, not by changes in membrane potential. They play a critical role in regulating neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization (AHP) following action potentials in neurons, modulating firing patterns and responsiveness to synaptic input patterns in both central nervous system neurons and cardiomyocytes, and in cardiac tissue integrating beat-to-beat changes in intracellular Ca²⁺ with membrane potential dynamics. Upregulation has been linked with atrial fibrillation pathophysiology.

Other names
KCNN2KCa2.2
02

Mechanism of action

Channel blocker

03

Biological functions

Regulation of neuronal excitabilityModulation of firing patternsRegulation of afterhyperpolarizationCardiac repolarization
04

Disease associations

Atrial fibrillationAngelman syndrome
05

Safety considerations

Potential for off-target effects on other potassium channelsArrhythmiasNeurological side effects
06

Interacting drugs

Apamin

Beyond the preview

Go deeper on Small conductance calcium-activated potassium channel protein 2 (SK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small conductance calcium-activated potassium channel protein 2 (SK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call